Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| PENG | Anne Kuykendall | SVP | 04/22/2026 | Verkauf | 27.92 | 738 | 20,605 | Form 4 |
| P | John Colgrove | Insider | 04/22/2026 | Verkauf | 70.50 | 82,266 | 5,799,753 | Form 4 |
| PBI | Lauren Freemen-Bosworth | EVP | 04/21/2026 | Verkauf | 14.25 | 169 | 2,408 | Form 4 |
| PTCT | Matthew B Klein | CEO | 04/21/2026 | Verkauf | 70.91 | 2,850 | 202,094 | Form 4 |
| PCRX | Shawn Cross | CFO | 04/21/2026 | Verkauf | 25.01 | 2,845 | 71,153 | Form 4 |
| PLMR | Mac Armstrong | CEO | 04/21/2026 | Verkauf | 130.77 | 3,500 | 457,695 | Form 4 |
| PRLD | David P Bonita | Director | 04/21/2026 | Kauf | 4.44 | 2,815,315 | 12,499,999 | Form 4 |
| PRLD | Orbimed Advisors Llc | Director | 04/21/2026 | Kauf | 4.44 | 2,815,315 | 12,499,999 | Form 4 |
| PRCH | Matt Ehrlichman | CEO | 04/21/2026 | Verkauf | 8.12 | 121,242 | 984,485 | Form 4 |
| PRCH | Matthew Neagle | COO | 04/21/2026 | Verkauf | 8.12 | 62,801 | 509,944 | Form 4 |
| PRCH | Shawn Tabak | CFO | 04/21/2026 | Verkauf | 8.12 | 7,730 | 62,768 | Form 4 |
| P | John Colgrove | Insider | 04/21/2026 | Verkauf | 70.06 | 16,840 | 1,179,810 | Form 4 |
| PCRX | Shawn Cross | CFO | 04/20/2026 | Verkauf | 25.14 | 7,714 | 193,930 | Form 4 |
| PAM | Marcos Marcelo Mindlin | Director | 04/20/2026 | Verkauf | 3.43 | 1,250,000 | 4,287,500 | Form 4 |
| PTGX | Asif Ali | CFO | 04/20/2026 | Verkauf | 105.47 | 1,750 | 184,573 | Form 4 |
| PTON | Charles Peter Kirol | COO | 04/20/2026 | Verkauf | 5.16 | 3,670 | 18,937 | Form 4 |
| PHR | Allison C Hoffman | General Counsel | 04/20/2026 | Verkauf | 9.06 | 6,176 | 55,955 | Form 4 |
| PAGS | Alexandre Mr Magnani | Director | 04/17/2026 | Verkauf | 11.26 | 200,000 | 2,252,000 | Form 4 |
| PHR | Yvonne Hui | Insider | 04/17/2026 | Verkauf | 9.28 | 1,327 | 12,315 | Form 4 |
| PRCH | Matt Ehrlichman | CEO | 04/17/2026 | Verkauf | 7.87 | 113,862 | 896,094 | Form 4 |
| PRCH | Matthew Neagle | COO | 04/17/2026 | Verkauf | 7.87 | 58,978 | 464,157 | Form 4 |
| PRCH | Shawn Tabak | CFO | 04/17/2026 | Verkauf | 7.87 | 8,367 | 65,848 | Form 4 |
| PGY | Tami Rosen | Director | 04/17/2026 | Verkauf | 15.14 | 9,720 | 147,161 | Form 4 |
| PODC | D Jonathan Merriman | Director | 04/17/2026 | Kauf | 2.11 | 10,200 | 21,522 | Form 4 |
| PODC | Ryan Carhart | Insider | 04/17/2026 | Kauf | 2.24 | 4,500 | 10,080 | Form 4 |
| PAX | D'Ippolito Marco Nicola | CEO of Global Private Markets | 04/14/2026 | Verkauf | 11.56 | 7,500 | 86,700 | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 03/31/2026 | Steuer-Abgabe | 5.90 | 38,664 | 228,118 | Form 4 |
| PCT | Carpenter Donald | Chief Financial Officer | 03/22/2026 | Steuer-Abgabe | 5.79 | 1,356 | 7,851 | Form 4 |
| PDEX | Domingo Angelita Rebamontan | Director | 03/16/2026 | Verkauf | 47.24 | 998 | 47,146 | Form 4 |
| PAYS | Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | 02/03/2026 | Verkauf | 4.16 | 15,057 | 62,637 | Form 4 |
| PAYS | Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | 11/13/2025 | Zuteilung | — | 233,333 | — | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 03/19/2025 | Zuteilung | — | 500,000 | — | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 03/19/2025 | Zuteilung | — | 2,500,000 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).